Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News New study sheds light on HIV progression

New study sheds light on HIV progression

12th October 2010

Scientists in the US have published new research which could be utilised in the future development of treatments for HIV-1.

According to data from the journal Science, a team including experts from the Scripps Research Institute and Pfizer conducted a study into cross-reactive neutralising antibodies, resulting in the discovery of three new monoclonal antibody types.

Among these was a pair of somatic variants with the ability to neutralise more than 90 per cent of circulating HIV-1 isolates, which could provide an insight into future vaccine designs.

Responding to the findings, HIV and Aids charity Nam said it "remains to be seen" whether this study can underpin future drug development, but suggested that there is cause for positivity.

Keith Alcorn, senior editor at Nam, stated that he expects more progress to be made towards a potential cure in the coming decade.

"It is going to take at least ten years before we know whether it is going to be possible at all to cure the infection but I'm more optimistic," he added.ADNFCR-8000103-ID-800111550-ADNFCR

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.